Relationships between physical dose quantities and patient dose in CT.

Department of Radiology, Humboldt University, Berlin, Germany.
British Journal of Radiology (Impact Factor: 1.22). 06/1999; 72(858):556-61.
Source: PubMed

ABSTRACT Patient dose in CT is usually expressed in terms of organ dose and effective dose. The latter is used as a measure of the stochastic risk. Determination of these doses by measurements or calculations can be time-consuming. We investigated the efficacy of physical dose quantities to describe the organ dose and effective dose. For various CT examinations of the head, neck and trunk, organ doses and effective doses were determined using conversion factors. Dose free-in-air on the axis of rotation (Dair) and weighted computed tomography dose index (CTDIw) were compared with the absorbed doses of organs which are located totally within the body region examined. Dose-length product (DLP) was compared with the effective dose. The ratio of the organ dose to CTDIw was 1.37 (0.87-1.79) mSv mGy-1. DLP showed a significant correlation with the effective dose (p < 0.005). The average ratio of effective dose to DLP was 0.28 x 10(-2) mSv (mGy cm)-1 for CT of the head, 0.62 x 10(-2) mSv (mGy cm)-1 for CT of the neck and 1.90 x 10(-2) mSv (mGy cm)-1 for CT of the trunk. CTDIw and DLP can be used for estimating the organ dose and effective dose associated with CT examinations of the head, neck and trunk.

  • [Show abstract] [Hide abstract]
    ABSTRACT: This work recommends dose reference levels (DRLs) for abdomen, chest and head computerised tomography (CT) examinations in Malta as the first step towards national CT dose optimisation. Third quartiles volume CT dose index values for abdomen: 12.1 mGy, chest: 13.1 mGy and head: 41 mGy and third quartile dose-length product values for abdomen: 539.4, chest: 492 and head: 736 mGy cm(-1) are recommended as Maltese DRLs derived from this first Maltese CT dose survey. These values compare well with DRLs of other European countries indicating that CT scanning in Malta is consistent with standards of good practice. Further work to minimise dose without affecting image quality and extending the establishment of DRLs for other CT examinations is recommended.
    Radiation Protection Dosimetry 10/2011; 150(2):198-206. · 0.91 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Computed tomography (CT) is used extensively in cancer diagnosis, staging, evaluation of response to treatment, and in active surveillance for cancer reoccurrence. A review of CT technology is provided, at a level of detail appropriate for a busy clinician to review. The basis of x-ray CT dosimetry is also discussed, and concepts of absorbed dose and effective dose (ED) are distinguished. Absorbed dose is a physical quantity (measured in milligray [mGy]) equal to the x-ray energy deposited in a mass of tissue, whereas ED uses an organ-specific weighting method that converts organ doses to ED measured in millisieverts (mSv). The organ weighting values carry with them a measure of radiation risk, and so ED (in mSv) is not a physical dose metric but rather is one that conveys radiation risk. The use of CT in a cancer surveillance protocol was used as an example of a pediatric patient who had kidney cancer, with surgery and radiation therapy. The active use of CT for cancer surveillance along with diagnostic CT scans led to a total of 50 CT scans performed on this child in a 7-year period. It was estimated that the patient received an average organ dose of 431 mGy from these CT scans. By comparison, the radiation therapy was performed and delivered 50.4 Gy to the patient's abdomen. Thus, the total dose from CT represented only 0.8% of the patient's radiation dose.
    Seminars in Oncology 02/2011; 38(1):128-35. · 4.33 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: OBJECTIVE. The purpose of this article is to quantify the CT radiation dose increment in five organs resulting from the administration of iodinated contrast medium. MATERIALS AND METHODS. Forty consecutive patients who underwent both un-enhanced and contrast-enhanced thoracoabdominal CT were included in our retrospective study. The dose increase between CT before and after contrast agent administration was evaluated in the portal phase for the thyroid, liver, spleen, pancreas, and kidneys by applying a previously validated method. RESULTS. An increase in radiation dose was noted in all organs studied. Average dose increments were 19% for liver, 71% for kidneys, 33% for spleen and pancreas, and 41% for thyroid. Kidneys exhibited the maximum dose increment, whereas the pancreas showed the widest variance because of the differences in fibro-fatty involution. Finally, thyroids with high attenuation values on unenhanced CT showed a lower Hounsfield unit increase and, thus, a smaller increment in the dose. CONCLUSION. Our study showed an increase in radiation dose in several parenchymatous tissues on contrast-enhanced CT. Our method allowed us to evaluate the dose increase from the change in attenuation measured in Hounsfield units. Because diagnostic protocols require multiple acquisitions after the contrast agent administration, such a dose increase should be considered when optimizing these protocols.
    American Journal of Roentgenology 06/2013; 200(6):1288-1293. · 2.90 Impact Factor


1 Download
Available from